Pediatrics:Chlamydia, Sickle Cell Anemia and Stroke Risk - Ancillary to STOP II
NCT00037388 · Status: COMPLETED · Type: OBSERVATIONAL
Last updated 2016-07-29
Summary
To establish a link among Chlamydia infection, sickle cell anemia, and stroke risk.
Conditions
- Blood Disease
- Anemia, Sickle Cell
- Chlamydia Infections
- Cerebrovascular Accident
Sponsors & Collaborators
-
National Heart, Lung, and Blood Institute (NHLBI)
lead NIH
Principal Investigators
-
Lori Styles · UCSF Benioff Children's Hospital Oakland
Eligibility
- Max Age
- 100 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2004-07-31
- Primary Completion
- 2006-06-30
- Completion
- 2006-06-30
More Related Trials
-
Prevention of Cerebral Infarction in Sickle Cell Anemia - Comprehensive Sickle Cell Center
NCT00005327 ·Status: COMPLETED
-
Hemostasis in Sickle Cell Disease--Infancy to Adulthood
NCT00005703 ·Status: COMPLETED
-
Aspirin Prophylaxis in Sickle Cell Disease
NCT00178464 ·Status: COMPLETED ·Phase: PHASE1
-
Silent Cerebral Infarct Transfusion Multi-Center Clinical Trial
NCT00072761 ·Status: COMPLETED ·Phase: PHASE3
-
Dense Red Blood Cells in Sickle Cell Children
NCT02887118 ·Status: TERMINATED
-
Induction of Stable Chimerism for Sickle Cell Anemia
NCT00029393 ·Status: COMPLETED ·Phase: PHASE2
-
Telemedicine for Children With Sickle Cell Disease
NCT05087303 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Longitudinal Changes in Exercise Capacity in Children and Young Adults With Sickle Cell Anemia
NCT01558076 ·Status: COMPLETED
-
Investigation of Selected Patient Groups From The Cooperative Study of Sickle Cell Disease
NCT00005300 ·Status: COMPLETED
-
Epidemiology of Silent and Overt Strokes in Sickle Cell Disease
NCT03376893 ·Status: ACTIVE_NOT_RECRUITING
-
State Of The Art Functional Imaging In Sickle Cell Disease
NCT01137721 ·Status: COMPLETED
-
Stroke Prevention in Young Adults With Sickle Cell Anemia
NCT04808778 ·Status: ACTIVE_NOT_RECRUITING
-
Penicillin Prophylaxis in Sickle Cell Disease (PROPS)
NCT00000585 ·Status: COMPLETED ·Phase: PHASE3
-
Screening for Renal Complications in Children and Young Adults With Major Sickle Cell Disease
NCT05211037 ·Status: COMPLETED ·Phase: NA
-
A Program to Increase Sickle Cell Trait Knowledge Among Parent of Young Children Identified in Newborn Screening
NCT03984500 ·Status: COMPLETED ·Phase: NA
-
Sickle Cell Disease: Targeting Alloantibody Formation Reduction; Risk Factors, and Genetics
NCT03288012 ·Status: UNKNOWN
-
Sickle Cell Disease Transplant Using a Nonmyeloablative Approach for Patients With Anti-donor Red Cell Antibody
NCT06358638 ·Status: RECRUITING ·Phase: PHASE2
-
Efficacy and Safety of Tocilizumab for Acute Chest Syndrome Treatment in Patients With Sickle Cell Disease
NCT06818266 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
Minimizing Toxicity in HLA-identical Sibling Donor Transplantation for Children With Sickle Cell Disease
NCT03587272 ·Status: RECRUITING ·Phase: PHASE2
-
Phase I/II Randomized Study of Hydroxyurea With or Without Clotrimazole in Patients With Sickle Cell Anemia
NCT00004492 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Sickle Cell Disease: A Retrospective Chart Review
NCT01441375 ·Status: COMPLETED
-
Exercise Capacity in Pediatric Sickle Cell Anemia
NCT01527799 ·Status: COMPLETED
-
Heart Disease in Sickle Cell Anemia
NCT00113152 ·Status: COMPLETED
-
Early Diagnosis of Sickle Acute Chest Syndrome Using a Combination of Plasma Bimarkers and Chest Imaging
NCT03478917 ·Status: COMPLETED
-
Genotype -Phenotype Correlation of PKLR Variants With Pyruvate Kinase, 2,3-Diphosphglycerate and Adenosine Triphosphate Activities in Red Blood Cells of People With Sickle Cell Disease
NCT03685721 ·Status: RECRUITING